Relationship between clinical pathological parameters and expression of CD90 in hepatocellular carcinoma
Huancheng ZHOU,Guangfu PENG,Yue SONG,Caiyun ZHANG,Jie WANG
DOI: https://doi.org/10.3969/j.issn.1009-5551.2016.02.019
2016-01-01
Abstract:Objective To investigate the relationship between clinical pathological parameters and expression of CD90 in hepatocellular carcinoma,and provide evidence for the treatment of HCC patients. Methods 80 HCC patients were selected with excision of liver cancer from department of hepatobiliary surgery,Sun Yixian Memorial Hospital of Zhongshan University from January 2010 to December 2012, and their HCC cancer tissues (HCC group ), para-carcinoma tissues (para-carcinoma group ) were collected.40 cases of normal liver tissues of liver trauma patients were collected (control group),The rela-tionship between clinical pathological parameters and expression of CD90 in different tissues was analyzed. Results Positive expression of CD90 was statistically significant between three groups (χ2=120.341;P <0.05 ).Expression of CD90 in HCC group and para-carcinoma group were higher than that in control group,the difference was statistically significant (Z =-8.519,-3.545;P <0.05).Expression of CD90 in HCC group was higher than that in para-carcinoma group,the difference was statistically significant (Z=-8.958;P <0.05).Expression of CD90 in HCC cancer tissues was related with tumor size,intrahepatic metastasis,TMN staging and pathologic grading (Z =- 2.204,- 2.728,- 3.085,- 4.068;P <0.05). 1 year survival rate and 2 years survival rate of CD90 positive patients were 87.67% ,63.01%,the differ-ence were not statistically significant (χ2 = 1.421,P = 0.233 ),and negative patients were 85.71%, 57.14% respectively,the difference were not statistically significan (χ2 =0.094,P =0.759).Conclusion The expression of CD90 increased in cancer tissues and para-carcinoma tissues,and was closely related with clinical pathological parameters,which can provide reference for diagnosis,treatment and prognosis evaluation of HCC patients.